Childhood apraxia of speech clinical trial
Speech disorders impacting children have debilitating impacts on educational, social and later employment outcomes. There are limited therapeutic…

Speech disorders impacting children have debilitating impacts on educational, social and later employment outcomes. There are limited therapeutic…
Redenlab, a leading provider of innovative solutions in the field of pediatric and neurodevelopment communication, proudly announces that…
L16HTHOUSE is a research trial testing an experimental medication for treating speech, motor, learning, and other developmental delays…
Speech and language development is a complex, multifactorial process driven by the individual’s ability to process and formulate…
For more information
If you are interested in seeing how Redenlab can help your organisation, please fill in the form and we’ll get in contact with you.
